129 related items for PubMed ID: 35522824
1. New predictors to identify severe cases during intravenous immunoglobulin therapy in Kawasaki disease.
Iwasa M, Inukai S.
Pediatr Int; 2022 Jan; 64(1):e15142. PubMed ID: 35522824
[Abstract] [Full Text] [Related]
2. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
Liu J, Ye B, Su D, Qin S, Zhao W, Pang Y.
Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
[Abstract] [Full Text] [Related]
3. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
Lu Y, Chen T, Wen Y, Si F, Wu X, Yang Y.
BMC Pediatr; 2021 Sep 16; 21(1):406. PubMed ID: 34530763
[Abstract] [Full Text] [Related]
4. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Sep 16; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
5. Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.
Nakagama Y, Inuzuka R, Hayashi T, Shindo T, Hirata Y, Shimizu N, Inatomi J, Yokoyama Y, Namai Y, Oda Y, Takamizawa M, Harita Y, Oka A.
Pediatr Int; 2016 Mar 16; 58(3):180-184. PubMed ID: 26222760
[Abstract] [Full Text] [Related]
6. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R, Shuai S, Zhang H, Cai J, Cui N, Tang M, Xing S, Gao Y, Liu X, Yang X.
Ital J Pediatr; 2023 Jun 25; 49(1):78. PubMed ID: 37357258
[Abstract] [Full Text] [Related]
7. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
Liu X, Wang L, Zhou K, Shao S, Hua Y, Wu M, Liu L, Wang C.
Pediatr Rheumatol Online J; 2021 Mar 12; 19(1):24. PubMed ID: 33712036
[Abstract] [Full Text] [Related]
8. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY, Ding Y.
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar 15; 25(3):244-249. PubMed ID: 36946157
[Abstract] [Full Text] [Related]
9. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
Int J Rheum Dis; 2013 Apr 15; 16(2):168-72. PubMed ID: 23773640
[Abstract] [Full Text] [Related]
10. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Apr 15; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
11. Poor response to intravenous immunoglobulin in patients with a parental history of Kawasaki disease.
Iwasa M, Inukai S.
Pediatr Int; 2022 Jan 15; 64(1):e14963. PubMed ID: 34411389
[Abstract] [Full Text] [Related]
12. [Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease].
Yuan YD, Sun J, Li PF, Wei CL, Yu YH.
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr 15; 19(4):410-413. PubMed ID: 28407827
[Abstract] [Full Text] [Related]
13. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.
Huang H, Jiang J, Shi X, Qin J, Dong J, Xu L, Huang C, Liu Y, Zheng Y, Hou M, Shen Q, Zeng B, Qian G, Yang F, Lv H.
Ann Med; 2022 Dec 15; 54(1):442-453. PubMed ID: 35099338
[Abstract] [Full Text] [Related]
14. Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.
Hashimoto I.
Pediatr Int; 2019 Jul 15; 61(7):641-646. PubMed ID: 31132210
[Abstract] [Full Text] [Related]
15. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
16. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
Arthritis Rheumatol; 2015 Jul 21; 67(7):1943-50. PubMed ID: 25778686
[Abstract] [Full Text] [Related]
17. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
Ha KS, Lee J, Lee KC.
Eur J Pediatr; 2020 Feb 21; 179(2):257-264. PubMed ID: 31713683
[Abstract] [Full Text] [Related]
18. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A, Pal P, Basu S.
Rheumatol Int; 2019 Oct 21; 39(10):1797-1801. PubMed ID: 31302740
[Abstract] [Full Text] [Related]
19. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
Li G, Wang T, Gou Y, Zeng R, Liu D, Duan Y, Liu B.
Int Immunopharmacol; 2020 Dec 21; 89(Pt A):107037. PubMed ID: 33242833
[Abstract] [Full Text] [Related]
20. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, Jain SS, Michalik DE, Sharma K, Truong DT, Wood JB, Kim KK, Jain S, KIDCARE Multicenter Study Group.
Lancet Child Adolesc Health; 2021 Dec 21; 5(12):852-861. PubMed ID: 34715057
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
